DeepHealth develops AI-powered, cloud-native health informatics and imaging solutions that optimise the entire radiology continuum - from detection and assessment through monitoring to treatment planning. The company's platform, DeepHealth OS, unifies clinical and operational data across radiology workflows whilst personalising AI-powered workspaces for different stakeholders within the imaging ecosystem.
The company's product portfolio spans Enterprise Imaging solutions for diagnostic and operational workflows, alongside specialised Population Health suites focused on breast, prostate, chest, thyroid and neuro imaging. DeepHealth's breast imaging suite alone supports more than 10 million mammograms annually across its deployments. The company's AI applications carry FDA clearance, and published studies have reported a 21% increase in breast cancer detection rates.
DeepHealth operates across 300+ sites globally and is a wholly-owned subsidiary of RadNet, Inc., a publicly listed healthcare company (NASDAQ: RDNT). The company positions itself within the intersection of medical imaging, artificial intelligence and health informatics, serving radiology enterprises and population health programmes.
